Last week was one of lots of gyrations, and as the result of a very substantial intraday reversal on Friday, the indices and our portfolios finished with small gains for the week. I am not about to call the bottom, yet. The market in general, and particularly the market in high-growth IT shares was oversold,…

To access this post, you must subscribe.

Read More

Can a high growth/high value name find happiness in the current investment environment ? Why write an article about GitLab’s (GTLB) now? GitLab shares are anything but the lowest valued shares, at least on an EV/S basis. They are, of course, much cheaper than they were immediately after their IPO. Even after a bit of recovery after…

To access this post, you must subscribe.

Read More

Jamf recently provided a very positive press release outlining strong business trends that seemingly exceeded expectations. Jamf’s business is to some extent correlated with the success of Apple’s Macintosh. Apple announced that Macintosh had achieved 25% revenue growth last quarter. Jamf’s press release spoke to closing 3 of the largest deals in the company’s history-and…

To access this post, you must subscribe.

Read More

Summary Shares of High-Growth software companies have led the market down so far in 2022. The decline in valuations and absolute share prices has been at rates that rival anything in the recent past. This decline has occurred against a background of strong and growing demand in the Information Technology (IT) space. Ironically, software demand…

To access this post, you must subscribe.

Read More

We made 2 changes in our model portfolios. As we have indicated in previous weekly commentaries, we sold our FIS position. We sold it at the opening this morning, 1/26 and we received $110.55. The proceeds of the sale netted $13,925. We originally bought the shares more than 4 years ago for $91.59. Obviously that…

To access this post, you must subscribe.

Read More

Last week was another week of distress for high-growth shares, although perhaps not as grim as the prior week. Most of the damage was done on Wednesday which brought substantial valuation contractions. The market for high-growth shares stabilized a bit on Friday, but overall, our high-growth portfolio lost 6% and its index value now stands…

To access this post, you must subscribe.

Read More

The New Decline: What’s been going on? More than a few subscribers and some readers on SA : How low is the market going? What should I be doing? How much longer will this bloodletting last? One subscriber wrote to me that he has been nauseous. He asked how I  stay calm. The reality is…

To access this post, you must subscribe.

Read More

Summary The valuations of high growth IT names have crashed. There has been little to be seen in the way of a bottom with share prices of IT names declining every day so far in this young year. Valuations, as I see them, looked at in terms of Enterprise Value/Sales (EV/S) ratios, but also free…

To access this post, you must subscribe.

Read More

Summary Alteryx has spent much of 2021 in the investor doghouse with the shares down.by about 50% over the past year. That share price performance belies some encouraging news in terms of the company’s operating performance, with ARR growth accelerating to 29% last quarter. In addition, customer churn has reduced to its lowest level since 2019, and…

To access this post, you must subscribe.

Read More

GAN: Continuing its journey as the pick and shovel vendor of the on-line gaming space; Teladoc (TDOC)-a completely misunderstood and underappreciated company. This is likely the last post to be sent before the Christmas holiday. For those of you who celebrate the holiday, the best wishes from our little group of Ticketeers. And for all…

To access this post, you must subscribe.

Read More